Items where authors include "Aslam, A"

Article

Saleem, B, Ross, RL, Bissell, L-A et al. (20 more authors) (2022) Effectiveness of SARS-CoV-2 vaccination in patients with rheumatoid arthritis (RA) on DMARDs: as determined by antibody and T cell responses. RMD Open, 8 (1). e002050. ISSN 2056-5933

Abani, O, Abbas, A, Abbas, F et al. (6300 more authors) (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10325). pp. 665-676. ISSN 0140-6736

Arnold, J, Vital, EM orcid.org/0000-0003-1637-4755, Dass, S et al. (5 more authors) (2022) A Personalized Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in ANCA-Associated Vasculitis. Frontiers in Immunology, 12. 803175. ISSN 1664-3224

Abani, O, Abbas, A, Abbas, F et al. (4809 more authors) (2021) Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. The Lancet, 397 (10289). pp. 2049-2059. ISSN 0140-6736

Abani, O orcid.org/0000-0003-2209-9956, Abbas, A, Abbas, F et al. (6346 more authors) (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285). pp. 1637-1645. ISSN 0140-6736

Roberts, I, Shakur-Still, H, Afolabi, A et al. (511 more authors) (2020) Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT) : an international randomised, double-blind, placebo-controlled trial. Lancet, 395 (10241). pp. 1927-1936. ISSN 0140-6736

Dubash, S, Pease, C, Aslam, A et al. (3 more authors) (2018) Acute Unilateral Sacroiliitis Mimicking Infection on Magnetic Resonance Imaging with Response to Nonsteroidal Antiinflammatory Drugs: A Distinct Presentation of Spondyloarthritis? The Journal of Rheumatology, 45. ISSN 0315-162X

Conference or Workshop Item

Arnold, J, Vital, E, Dass, S et al. (5 more authors) (2021) A Personalised Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in Anca-Associated Vasculitis. In: EULAR 2021, 02-05 Jun 2021, Virtual.

Arnold, JE, Vital, EMJ, Dass, S et al. (5 more authors) (2021) P207 A proposal for individually tailored rituximab treatment based on clinical and B-cell biomarkers for remission maintenance in ANCA associated vasculitis. In: British Society for Rheumatology Annual Conference 2021, 26-28 Apr 2021, Online.

Proceedings Paper

Ouboussad, L, Hunt, L, Wong, C et al. (4 more authors) (2018) Investigating IL-6 intracellular signalling in peripheral blood cell subsets in patients at early and later stages of rheumatoid arthritis (RA). In: Annals of the Rheumatic Diseases. 38th European Workshop for Rheumatology Research, 22-24 Feb 2018, Geneva, Switzerland. BMJ Publishing Group , A31-A32.

Ouboussad, L, Wong, C, Hunt, L et al. (4 more authors) (2017) Effect of tocilizumab therapy on il-6 signalling pathway in early rheumatoid arthritis patients. In: Annals of the Rheumatic Diseases. EWRR, 02-04 Mar 2017, Athens. BMJ Publishing Group , A40-A40.